Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by TexRitteron Dec 20, 2017 8:11pm
347 Views
Post# 27200885

RE:Aurora share price once Cannimed is acquired................

RE:Aurora share price once Cannimed is acquired................I think up to 9 within 2- 3 days, and I think up to 12 by end of January. If Cannimed was about 15 prior to the takeover bid situation starting up, and Aphria is currently 14 plus, there is no way that we are not approaching that number by end of January. with pending legalization in the news. We will have everything Aurora has going for it with respect to production capacity and international distribution, Auoroa's growing customer list then doubled with Cannimed's, the Pharmachoice deal, and probably by then the pick and shovel acquisitions will start paying off, here and internationally.

It will be Canopy Growth at number one, but suddenly Aurora Cannabis leapfrogs Aphria not just to 2, but possibly to 1A. Csnopy is still a great investment at 20 something, and will be the first 30 dollar marijuana stock But Auroroa - if the takeover is successful - will be the 2nd to 20 dollars, and will be closing the gap approaching 30. Their facilities are expensive now and have some people fretting over valuation which is so inaccurate for this sector right now. \But those facilities will pay off once fully operational, with the lowest production costs and most efficient output. This stock is a long play, not a short play. Same with Canopy. Here's hoping both become 50 dollar stocks by 2020. I have much more in Aurora than Canopy, but I think that good things for one will in many ways equal good things for the other. There are lots of people playing the short term in cannabis - look at how many companies are popping up. I'm looking at lots. but I continue to come back to these 2 and a small number of others. .
Bullboard Posts